Ibex and PathPresenter Partner to Advance AI-powered Digital Pathology Solutions
Ibex Medical Analytics (Ibex) and PathPresenter announced a partnership to advance the adoption of AI-powered digital pathology.
Read More
Search Results for: prostate cancer
How Disease Surveillance Will Help Spot Disease X
Picodya has developed a scalable solution that is being used by the NIH to find Disease X and stop the next pandemic in its tracks.
Read More
Protein Biomarker Identified for Aggressive Neuroendocrine Carcinomas Diagnosis
New research is guiding the development of blood tests to detect and monitor responses to therapies in neuroendocrine carcinomas patients.
Read More
New Epigenomic Technology Platform Predicts Immunotherapy Response in NSCLC Patients
The epigenomic technology platform predicts and monitors immunotherapy responses for patients with non-small cell lung cancer (NSCLC).
Read More
NIH Deploys Picodya’s IVD Platform to Detect Global Viral Threats
Picodya, the creator of a hybrid IVD solution for multiplexed POC testing, announced the deployment of its B-Matrix technology in NIH labs.
Read More